Nathan Croft

Nathan Croft is a Senior Lecturer in Biochemistry & Molecular Biology at Monash University, Australia. He transitioned to Monash in 2012 after postdoctoral work at the University of Melbourne. His research focuses on MHC antigen processing pathways, T cell immunity, and developing bioinformatics tools for immunopeptidomics. He holds a PhD from the University of Birmingham (2009), where he studied Epstein-Barr Virus immune evasion.

Research Interests: Nathan's work bridges immunology and bioinformatics, with a focus on understanding how MHC-peptide abundance influences T cell responses to pathogens and tumors. Key areas include peptide repertoire mapping, immunopeptidome analysis, and developing computational tools like Immunolyser and MHCpLogics. His projects address viral immunology, cancer antigen discovery, and drug-induced antigen modifications.

Grants & Collaborations: He co-led an NHMRC-funded project (2015–2019) on T cell recognition of virus-infected cells. Collaborations span institutions globally, with notable work on SARS-CoV-2 antigen analysis and N-glycan remodelling in MHC-II presentation.

Education: PhD in Immunology (University of Birmingham, 2009). Academic Background: Postdoctoral positions at the University of Melbourne (2009–2012) before joining Monash.

Professional Activities: Member of Monash's Biochemistry & Molecular Biology unit (2018–2020). Actively supervises PhD students and contributes to open-access research dissemination.